Skip to main content

Advertisement

ADVERTISEMENT

Insights

Headshot of Jeffrey Stark on a blue background underneath the PopHealth Perspectives logo.
Videos
07/26/2021
Jeffrey Stark, MD, head of immunology medical affairs, UCB, breaks down the unique challenges patients with psoriasis face, and discusses the BE RADIANT and BE SURE studies, both of which indicated that bimekizumab was effective at achieving...
Jeffrey Stark, MD, head of immunology medical affairs, UCB, breaks down the unique challenges patients with psoriasis face, and discusses the BE RADIANT and BE SURE studies, both of which indicated that bimekizumab was effective at achieving...
Jeffrey Stark, MD, head of...
07/26/2021
First Report Managed Care
Commentary
07/08/2019
Lawrence Green, MD, associate clinical professor of dermatology at George Washington University School of Medicine, reviews current biologic therapies available for psoriasis and shares his methods for selecting the appropriate biologic for...
Lawrence Green, MD, associate clinical professor of dermatology at George Washington University School of Medicine, reviews current biologic therapies available for psoriasis and shares his methods for selecting the appropriate biologic for...
Lawrence Green, MD, associate...
07/08/2019
First Report Managed Care
Interview
03/14/2019
In this discussion, Jeffery Weinberg, MD, medical dermatologist at Mount Sinai School of Medicine, and Megan Noe, MD, MPH, dermatologist at the University of Pennsylvania, highlight the new psoriasis treatment guidelines released by NPF and...
In this discussion, Jeffery Weinberg, MD, medical dermatologist at Mount Sinai School of Medicine, and Megan Noe, MD, MPH, dermatologist at the University of Pennsylvania, highlight the new psoriasis treatment guidelines released by NPF and...
In this discussion, Jeffery...
03/14/2019
First Report Managed Care

Advertisement

Advertisement